Cardiac Ultrasound, or CUS, is a non-invasive imaging technique that visualizes the heart’s structure and function. Given the rising prevalence of heart diseases including heart attack, heart failure, stroke, heart rhythm disorders, etc., CUS serves as an indispensable tool to ensure early condition detection and prompt management. Handheld CUS devices significantly elevate the standard of care by enabling immediate bedside assessments which streamlines imaging at the point of care. The revolutionary AI integration further ensures rapid, accurate decisions and optimizes treatment pathways.
Cardiac Ultrasound provides clinicians with a comprehensive view of the heart’s chambers, valves, and surrounding structures. It enhances the understanding of both congenital and acquired anomalies by revealing important details about the heart’s anatomy. Real-time imaging allows for dynamic assessments during the cardiac cycle, facilitating the identification of abnormalities such as blood clots or pericardial effusions.
Cardiac Ultrasound is crucial for assessing heart function, particularly through the measurement of ejection fraction (EF). This metric indicates the heart’s pumping efficiency and serves as a key indicator for diagnosing heart failure. Accurate EF assessment helps monitor treatment effectiveness and identify wall motion abnormalities (WMA) that may signal ischemic heart disease.
Through Doppler imaging, CUS assesses blood flow velocities, allowing for the detection of conditions such as valve stenosis and regurgitation. By quantifying velocity and pressure gradients, clinicians can determine the severity of valvular diseases. It further aids in formulating targeted treatment plans, enhancing patient care, and ultimately improving clinical outcomes.
